Inhibition of hypothalamic neuropeptide Y gene expression by insulin. 1992

M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
Department of Medicine, University of Washington, Seattle.

Insulin acts in the brain to suppress feeding, whereas neuropeptide Y (NPY) has the opposite effect. Since fasting lowers plasma insulin levels and increases hypothalamic synthesis of NPY, we proposed that insulin may inhibit hypothalamic NPY gene expression. To test this hypothesis, we used RIA and in situ hybridization histochemistry to determine if centrally administered insulin could reduce levels of both NPY and its messenger RNA (mRNA) in discreet hypothalamic regions during fasting. Three groups of Long-Evans rats were entered into a 72-h study protocol. One group was fed ad libitum during this period, while the others were fasted. Fed rats received intracerebroventricular (icv) injections of saline vehicle at 12-h intervals, whereas fasted groups received icv vehicle alone or with insulin (4 mU/12 h). In vehicle-only treated rats, fasting significantly increased expression of preproNPY mRNA in the arcuate nucleus to 179 +/- 20% of fed controls. Administration of icv insulin during fasting abolished this increase (99 +/- 14% of fed controls; P less than 0.05 vs. fasted, vehicle-treated rats). Central insulin administration during fasting also reduced immunoreactive NPY concentrations in samples punched from the paraventricular nucleus (PVN) (875 +/- 122 pg/punch) to levels below vehicle-only treated rats (1396 +/- 435 pg/punch; P less than 0.05), similar to free-feeding control values (814 +/- 170 pg/punch). By comparison, neither fasting nor central insulin administration altered NPY levels in four other hypothalamic regions (supraoptic, ventromedial, dorsomedial, and arcuate nuclei). Continuous icv insulin infusion at a lower dose (2 mU/day) produced a similar result during a shorter period (48 h) of food deprivation in Wistar rats. In this study, central insulin infusion also inhibited the fasting-related increase in arcuate preproNPY mRNA levels and did not affect plasma glucose or insulin levels. This suggests that insulin acts locally to inhibit hypothalamic NPY mRNA expression. We conclude that the increase of levels of NPY in the PVN and preproNPY mRNA in the arcuate nucleus during fasting are inhibited by icv insulin. Fasting, therefore, increases NPY biosynthesis along an arcuate nucleus-PVN pathway in the hypothalamus via a mechanism dependent on low insulin levels.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D011498 Protein Precursors Precursors, Protein
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger

Related Publications

M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
June 1992, Endocrinology,
M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
May 1994, The American journal of physiology,
M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
November 1997, Brain research,
M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
September 1992, Brain research. Molecular brain research,
M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
September 1998, The American journal of physiology,
M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
January 2000, Nihon rinsho. Japanese journal of clinical medicine,
M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
February 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
December 1992, Brain research. Molecular brain research,
M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
August 1990, Molecular and cellular neurosciences,
M W Schwartz, and A J Sipols, and J L Marks, and G Sanacora, and J D White, and A Scheurink, and S E Kahn, and D G Baskin, and S C Woods, and D P Figlewicz
July 1996, Nature,
Copied contents to your clipboard!